XTNT
Xtant Medical Holdings Inc
NYSE MKT: XTNT · HEALTHCARE · MEDICAL DEVICES
$0.52
-3.93% today
Updated 2026-04-30
Market cap
$74.07M
P/E ratio
17.63
P/S ratio
0.55x
EPS (TTM)
$0.03
Dividend yield
—
52W range
$0 – $1
Volume
0.1M
Xtant Medical Holdings Inc (XTNT) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$0.52
12-Month target
$0.30
2030 Target
—
Intrinsic (DCF)
$3.01
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 17.63x (capped 25x) · Margin: 3.71%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.